JPY2,628.00
1.28%
Tokyo, Aug 12, 08:15 am CET
ISIN
JP3256000005
Symbol
4151
Index

Kyowa Kirin Stock price

JPY2,620.00
+145.00 5.86% 1M
+550.00 26.57% 6M
+244.50 10.29% YTD
-346.50 11.68% 1Y
-565.00 17.74% 3Y
-64.00 2.38% 5Y
+594.00 29.32% 10Y
+1,838.00 235.04% 20Y
Tokyo, Closing price Tue, Aug 12 2025
-42.00 1.58%
ISIN
JP3256000005
Symbol
4151
Index
Industry

Key metrics

Basic
Market capitalization
JPY1.4t
Enterprise Value
JPY1.2t
Net debt
positive
Cash
JPY215.6b
Shares outstanding
523.4m
Valuation (TTM | estimate)
P/E
27.1 | 24.0
P/S
2.8 | 2.9
EV/Sales
2.4 | 2.5
EV/FCF
negative
P/B
1.7
Dividends
DPS
JPY60.00
Yield 1Y | 5Y
2.3% | 1.9%
Growth 1Y | 5Y
3.4% | 6.4%
Payout 1Y | 3Y
51.3% | 45.4%
Increased
9 Years
Financials (TTM | estimate)
Revenue
JPY494.7b | JPY479.8b
EBITDA
JPY102.9b | JPY107.2b
EBIT
JPY77.7b | JPY99.0b
Net Income
JPY51.4b | JPY58.0b
Free Cash Flow
JPY-54.4b
Growth (TTM | estimate)
Revenue
8.9% | -3.2%
EBITDA
-7.5% | 4.6%
EBIT
-22.6% | 9.1%
Net Income
-38.1% | -3.1%
Free Cash Flow
-174.6%
Margin (TTM | estimate)
Gross
73.4%
EBITDA
20.8% | 22.4%
EBIT
15.7%
Net
10.4% | 12.1%
Free Cash Flow
-11.0%
Financial Health
Equity Ratio
79.7%
Return on Equity
7.0%
ROCE
8.8%
ROIC
8.2%
Debt/Equity
0.0
More
EPS
JPY98.2
FCF per Share
JPY-103.9
Short interest
-
Employees
6k
Rev per Employee
JPY87.4m
Show more

Is Kyowa Kirin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Kyowa Kirin Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Kyowa Kirin forecast:

8x Buy
53%
6x Hold
40%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a Kyowa Kirin forecast:

Buy
53%
Hold
40%
Sell
7%

Financial data from Kyowa Kirin

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
494,713 494,713
9% 9%
100%
- Direct Costs 131,614 131,614
12% 12%
27%
363,099 363,099
8% 8%
73%
- Selling and Administrative Expenses 166,325 166,325
10% 10%
34%
- Research and Development Expense 108,786 108,786
38% 38%
22%
102,940 102,940
7% 7%
21%
- Depreciation and Amortization 25,278 25,278
131% 131%
5%
EBIT (Operating Income) EBIT 77,662 77,662
23% 23%
16%
Net Profit 51,404 51,404
38% 38%
10%

In millions JPY.

Don't miss a Thing! We will send you all news about Kyowa Kirin directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Masashi Miyamoto
Employees 5,669
Founded 1949
Website www.kyowakirin.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today